ATG5 Gene: Autophagy Related 5

A key regulator of autophagy and its implications in human disease

Gene Information Card

Symbol ATG5
Full Name Autophagy Related 5
Gene Type Protein coding
Chromosomal Location 6q21
NCBI Gene ID 9474 ncbi.nlm.nih.gov/gene/9474
Ensembl ID ENSG00000057608
UniProt ID Q9H1Y0
OMIM ID 604261
HGNC ID 589
Aliases APG5, APG5L, ASP, hAPG5

Description

ATG5 (Autophagy Related 5) encodes a protein that is essential for autophagosome formation, a key step in macroautophagy. The ATG5 protein forms a conjugate with ATG12, which then associates with ATG16L1 to form a complex that promotes the lipidation of LC3 (MAP1LC3A) at the autophagosome membrane. This process is critical for the degradation and recycling of cytoplasmic components, including damaged organelles and protein aggregates. ATG5 also plays roles in other cellular processes such as apoptosis, immune response, and tumor suppression. Mutations and dysregulation of ATG5 have been linked to various diseases, including neurodegenerative disorders, inflammatory conditions, and cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Spinocerebellar ataxia type 35 Biallelic loss-of-function mutations in ATG5 impair autophagy, leading to neuronal degeneration. OMIM #604261; PMID: 27545674
Ataxia, developmental delay, and intellectual disability Homozygous missense mutations in ATG5 disrupt autophagosome formation, affecting neurodevelopment. OMIM #604261; PMID: 27545674
Inflammatory bowel disease (susceptibility) ATG5 variants may alter autophagy in intestinal epithelium, affecting immune homeostasis. ClinVar; PMID: 23128233
Cancer (various types) Dysregulation of ATG5 expression can promote tumorigenesis by modulating autophagy and apoptosis. COSMIC; PMID: 25644177

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 10.2 Medium
Heart 8.5 Medium
Liver 7.8 Medium
Kidney 9.1 Medium
Lung 6.4 Low
Skeletal muscle 5.2 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 12.3 Cervical cancer cell line; high expression
HEK293 11.8 Embryonic kidney; high expression
MCF7 9.5 Breast cancer; moderate expression
A549 8.2 Lung carcinoma; moderate expression
HepG2 7.9 Liver cancer; moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.Glu122Asp Missense Rare Impairs ATG5-ATG12 conjugation, reducing autophagy
p.Arg134His Missense Rare Disrupts ATG5-ATG16L1 interaction, affecting autophagosome formation
c.IVS1+1G>A Splice site Rare Splicing defect leading to loss of function
p.Leu200Phe Missense Rare Alters protein stability and autophagy activity
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in ATG5 impair autophagosome formation, leading to accumulation of damaged proteins and organelles, contributing to neurodegeneration and developmental disorders.

Gain of Function (GOF)

No clear gain-of-function mutations have been reported; ATG5 is primarily a tumor suppressor, and overexpression may promote autophagy but is not typically oncogenic.

Dominant Negative (DN)

Some missense mutations may act in a dominant-negative manner by interfering with the ATG5-ATG12-ATG16L1 complex, but evidence is limited.

Gene Ontology (GO)

• autophagy • protein conjugation
• ATG12 transferase activity • ubiquitin-like protein conjugation
• autophagosome assembly • response to starvation
• apoptotic process • cellular response to oxidative stress

Pathways

Autophagy - animal
Mitophagy
Selective autophagy
LC3-I to LC3-II conversion
ATG5-ATG12 conjugation pathway

Protein Summary

The ATG5 protein is a 275-amino acid protein that is essential for autophagy. It forms a covalent conjugate with ATG12 via a ubiquitin-like conjugation system, and this conjugate interacts with ATG16L1 to form a multimeric complex. This complex is required for the lipidation of LC3-I to LC3-II, which is a critical step in autophagosome membrane elongation and closure. ATG5 also has autophagy-independent functions, including roles in apoptosis, antigen presentation, and regulation of innate immune signaling. Its expression is ubiquitous, with higher levels in tissues with high metabolic activity. Mutations in ATG5 are rare but can cause severe neurological phenotypes when biallelic.

Related Products

Product name Cat.No. Species Gene ID
ATG5 Knockout HEK293 Cell Line EDJ-KQ12467 Human 9474 Details Get a Quote
ATG5 Knockout HeLa Cell Line EDJ-KQ18163 Human 9474 Details Get a Quote
ATG5 Knockout A-549 Cell Line EDJ-KQ41412 Human 9474 Details Get a Quote
ATG5 Knockout HCT 116 Cell Line EDJ-KQ41413 Human 9474 Details Get a Quote
ATG5 Knockout Huh-7 Cell Line EDJ-KZ1 Human 9474 Details Get a Quote
ATG5 Knockout NCI-H1299 Cell Line EDJ-KZ10 Human 9474 Details Get a Quote
ATG5 Knockout PK-15 Cell Line EDJ-KZ100 Pig 100739102 Details Get a Quote
ATG5 Knockout E6 Cell Line EDJ-KZ559 African green monkey 103240649 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: